Cell and Gene Therapy World Congress 2024 Europe
"Driving Innovation, Addressing Significant Unmet Medical Needs, and Ultimately Improving Patient Outcomes"
3rd - 4th October 2024, Hilton London Kensington, LONDON, UK
KEY INDUSTRY EXPERT SPEAKERS
- Eric Halioua, President & Chief Executive Officer, PDC*line Pharma
- Alex Blyth, Founder & CEO, Lift Biosciences
- Alexander Natz, Secretary General, EUCOPE
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr. Ron Jortner, Founder/CEO, Aspire Biosciences
- Prof Harris Makatsoris, Professor of Manufacturing Systems, Department of Engineering, King’s College
- Jeff Liter, CEO, OX2 Therapeutics
- Eugean Jiwanmall, Senior Research Analyst, Independence Blue Cross
- Mohamed Oubihi, Founder and CEO, YAKUMED LIMITED
- Marco Traub, CEO, The Trans European Stem Cell Therapy Society
- Adam Glen, Co-founder, Unicorn Bio
- Dr Theres Oakes, Head of Product Characterisation, Achilles Therapeutics
- Zhimei Du MD, VP of Process Sciences, Atara Biotherapeutics
- Wenliang Dong, Chief Operating Officer, ORCA Therapeutics
- Mohamed Oubihi, Founder and CEO, YAKUMED LIMITED
- Alberto Malerba, Lecturer in Gene Therapy, Royal Holloway University of London
- Anthony Newcomb, Chief Operating Officer, VectorY
- Eugean Jiwanmall, Senior Research Analyst, Independence Blue Cross
- Cecilia Gotherstrom, Research Group leader, Associate Professor in Stem Cell Science, Karolinska Institute
- Stephen Judd, Process SME – Biologics / Cell & Gene Therapy, DPS Group
- Dr. Anand Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research
- Amir Hefni, Global Head, Cell & Gene Therapy, Novartis
- Stefanos Theoharis, Independent Expert
- Alejandro Fernandez-Martell, former Principal Bioprocess Engineer, Achilles Therapeutics
- Stuart M Curbishley, Chief Manufacturing and Chief Development Officer, adthera bio
- Elsa Abranches, Sr Director,Head of Cell Therapy Bioprocess Development and Manufacturing, Astrazeneca*
- Ben Doak, Head of Innovative Treatments, NHS England.
- Mark Fowler, Global Head of Procurement, Autolus
- Francois Hallac, Research Associate, King's College London
- Julia Djonova, Head, Advanced Therapy Medicinal Products, Swissmedic
- Thomas Muller, Head Of Directorate General, Federal Ministry of Health Germany
- Manal Morsy, EVP, Head of Global Regulatory Affairs, Athersys, Inc
- Yue (Dina) Du, Senior Scientist, Gene Therapy R&D, AstraZeneca
- Reagan Jarvis, Chief Executive Officer and Co-founder, Anocca
- Matthias Bozza, Director, Vector BioPharma
- Chris Williams, SVP Corporate Development, Autolus Ltd.
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr. Thomas Schochat, Clinical Assessor, Division Advanced Therapy Products, Swissmedic
- Daniel Gibson, Director of Cell and Gene, Anthony Nolan
- Vera Citro, P4FIT Early Stage Researcher, Keele University
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/02/E-HALIOUA.png)
Eric Halioua
President & Chief Executive Officer
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/J-Liter.png)
JEFF LITER
CEO
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/A-Blyth.png)
ALEX BLYTH
Founder & CEO
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/A-Natz-3.png)
ALEXANDER NATZ
Secretary General
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/10/L-Hook-1.png)
DR LILIAN HOOK
Director Cell, Apheresis & Gene Therapies
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/RJortner-1.png)
DR. RON JORTNER
Founder/CEO
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/Charalampos.png)
PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering
King’s College London
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/Charalampos.png)
PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/Eugean-5.png)
EUGEAN JIWANMALL
Senior Research Analyst
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/M-Traub.png)
MARCO TRAUB
CEO
![](https://www.cell-genetherapy.com/wp-content/uploads/2024/07/A-Glen.png)
ADAM GLEN
Co-founder
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/10/D-Gibson.png)
Daniel Gibson
Director of Cell and Gene
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/02/A-Hefni.png)
Amir Hefni
Global Head for Cell & Gene Therapy
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/02/Stefanos.png)
Stefanos Theoharis
Senior Executive
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/02/Anand.png)
Dr. Anand Srivastava
Chairman and Co-founder
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/M-Morsy.png)
MANAL MORSY
Executive Vice President, Head of Global Regulatory Affairs
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/T-Muller.png)
THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”
Federal Ministry of Health, Germany
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/T-Muller.png)
THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/R-Jarvis.png)
REAGAN JARVIS
CEO and Co-founder
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/B-Doak.png)
BEN DOAK
Head of Innovative Treatments
![](https://www.cell-genetherapy.com/wp-content/uploads/2022/11/1605704106606.jpg)
CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science
Karolinska Institutet
![](https://www.cell-genetherapy.com/wp-content/uploads/2022/11/1605704106606.jpg)
CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science
![](https://www.cell-genetherapy.com/wp-content/uploads/2022/10/Alberto-Malerba-Photo2.jpg)
ALBERTO MALERBA
Lecturer in Gene Therapy
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/S-Curbishley.png)
STUART M CURBISHLEY
Chief Manufacturing and Chief Development Officer
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/10/j-Djunova-1.png)
JULIA DJONOVA
Head, Advanced Therapy Medicinal Products
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/C-williams.png)
Dr Chris Williams
SVP Corporate Development
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/10/T-Schochat.png)
Dr. Thomas Schochat
Clinical Assessor, Division Advanced Therapy Products
![](https://www.cell-genetherapy.com/wp-content/uploads/2023/09/M-Bozza.png)
MATTHIAS BOZZA
Director